| (210) | Number of the EPO application | 18801031 |
| (220) | Filing date of the EPO application | 2018.10.17 |
| (80) | EPO patent specification publication (B) | EPB nr. 03/2023, 2023.01.18 |
| (110) | EPO patent number | 3697790 |
| (21) | Number of the application | e 2020 0861 |
| (71) | Name(s) of applicant(s), code of the country | Suven Life Sciences Limited, IN; |
| (72) | Name(s) of inventor(s), code of the country | NIROGI Ramakrishna, IN;
MOHAMMED Abdul Rasheed, IN;
SHINDE Anil Karbhari, IN;
RAVELLA Srinivas, IN;
MIDDEKADI Vanaja, IN;
GOYAL Vinod Kumar, IN;
JAYARAJAN Pradeep, IN;
DARIPELLI Saivishal, IN;
JASTI Venkateswarlu, IN; |
| (73) | Name(s) of owner(s), code of the country | Suven Life Sciences Limited, IN; |
| (54) | Title of the invention | HETEROARYL COMPOUNDS AS MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 487/04 (2006.01.01); A61K 31/519 (2006.01.01); A61P 25/00 (2006.01.01) |
| (19) | Country | IN |
| (41) | Date of publication of the application | 2020.09.30 |
| (30) | Priority | 201741037090, 2017.10.18, IN |
| (86) | International application | PCT/IB2018/058047, 2018.10.17 |
| (87) | International publication | WO 2019/077517, 2019.04.25 |